Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents

Bioconductor: open software development for computational biology and bioinformatics

Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,082

Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829

Exploring the full spectrum of macrophage activation

Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144

Macrophage Diversity Enhances Tumor Progression and Metastasis

Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,349

Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393

Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Bielack, S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.776 · Cited by 2,391

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

Martinez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,125

lumi : a pipeline for processing Illumina microarray

Du, P., Kibbe, W. A., & Lin, S. M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn224 · Cited by 2,028

How dying cells alert the immune system to danger

Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737

Immunological aspects of cancer chemotherapy

Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712

Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes

Song, Y., Xu, Y., Deng, C., Zhu, X., Fu, J., Chen, H., Lu, J., Xu, H., Song, G., Tang, Q., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.623762 · Cited by 26

Immunotherapy in Pediatric Solid Tumors—A Systematic Review

Marayati, R., Quinn, C. H., & Beierle, E. A. (2019) · Cancers · doi:10.3390/cancers11122022 · Cited by 27

Role of microRNAs in the crosstalk between osteosarcoma cells and the tumour microenvironment

Lei, Y. H., Junxin, C., Huang, Y., Xiaoguang, L., & Yu, B.-S. (2020) · Journal of bone oncology · doi:10.1016/j.jbo.2020.100322 · Cited by 25

Prognostic Implications of the Complement Protein C1Q and Its Correlation with Immune Infiltrates in Osteosarcoma

Huang, H., Tan, M., Li, Z., Yan, G., Li, K., Lu, D., Cui, X., He, S., Lei, D., Zhu, B., et al. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s295063 · Cited by 25

Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma

Yang, J., Zhang, J., Na, S., Wang, Z., Li, H., Su, Y., Ji, L., Tang, X., Yang, J., & Lu, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.994034 · Cited by 25

Current Landscape of Immunotherapy for Advanced Sarcoma

Albarrán, V., Villamayor, M. L., Pozas, J., Chamorro, J., Rosero, D. I., Román, M. S., Guerrero, P., de Aguado, P. P., Calvo, J. C., de Quevedo, C. G., et al. (2023) · Cancers · doi:10.3390/cancers15082287 · Cited by 25

Development of a prognostic gene signature based on an immunogenomic infiltration analysis of osteosarcoma

Yu, Y., Zhang, H., Ren, T., Huang, Y., Liang, X., Wang, W., Niu, J., Han, Y., & Guo, W. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15687 · Cited by 25

Application of Immune Infiltration Signature and Machine Learning Model in the Differential Diagnosis and Prognosis of Bone-Related Malignancies

Li, G.-Q., Wang, Y.-K., Zhou, H., Jin, L.-G., Wang, C.-Y., Albahde, M., Wu, Y., Li, H.-Y., Zhang, W.-K., Li, B.-H., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.630355 · Cited by 24

Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability

Pierrevelcin, M., Fuchs, Q., Lhermitte, B., Messé, M., Guérin, É., Weingertner, N., Martin, S., Lelong-Rebel, I. H., Nazon, C., Dontenwill, M., et al. (2020) · Cells · doi:10.3390/cells9091998 · Cited by 28

Magnetic resonance imaging of tumor-associated-macrophages (TAMs) with a nanoparticle contrast agent

Zhou, J., Meli, V. S., Chen, E. Y., Kapre, R., Nagalla, R. R., Xiao, W., Borowsky, A. D., Lam, K. S., Liu, W. F., & Louie, A. Y. (2022) · RSC Advances · doi:10.1039/d1ra08061j · Cited by 24

Asiaticoside reverses M2 phenotype macrophage polarization-evoked osteosarcoma cell malignant behaviour by TRAF6/NF-κB inhibition

Li, D.-K., & Wang, G. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2109688 · Cited by 24

Engineering Novel 3D Models to Recreate High‐Grade Osteosarcoma and its Immune and Extracellular Matrix Microenvironment

Pierrevelcin, M., Flacher, V., Mueller, C. G., Vauchelles, R., Guérin, É., Lhermitte, B., Pencreach, E., Reisch, A., Muller, Q., Doumard, L., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202200195 · Cited by 25

Biomaterials‐Boosted Immunotherapy for Osteosarcoma

Sun, C., Li, S., & Ding, J. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400864 · Cited by 25

Advancing osteosarcoma 3D modeling in vitro for novel tumor microenvironment-targeted therapies development

Costa, S. A., Rodrigues, J., Vieira, C., Dias, S., Viegas, J. S. R., Castro, F., Sarmento, B. F. C. C., & Pereira, C. L. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.068 · Cited by 24

Tumor microenvironment in osteosarcoma: From cellular mechanism to clinical therapy

Yu, Y., Li, K., Peng, Y., Zhang, Z., Pu, F., Shao, Z., & Wu, W. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101569 · Cited by 26

Bisphosphonates in common pediatric and adult bone sarcomas

Heymann, M., Lézot, F., & Heymann, D. (2020) · Bone · doi:10.1016/j.bone.2020.115523 · Cited by 23

Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2+ γδ T cell cytotoxicity in a perforin-dependent manner

Fowler, D. W., Copier, J. P., Dalgleish, A. G., & Bodman‐Smith, M. D. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2011-1 · Cited by 23

CONUT Score or/and Peripheral Blood CD4+/CD8+ Ratio-Based Web Dynamic Nomograms to Predict the Individualized Survival of Patients with Advanced Osteosarcoma

Yang, Q., Su, Y., Wang, W., Wang, N., Yao, Z., & Zhang, X. (2020) · Cancer Management and Research · doi:10.2147/cmar.s251814 · Cited by 23

Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights

Zhang, Y., Jiang, S., Lv, J., Feng, W., Yu, Y., & Zhao, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1584450 · Cited by 22

Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene

Barøy, T., Chilamakuri, C. S. R., Lorenz, S., Sun, J., Bruland, Ø. S., Myklebost, O., & Meza‐Zepeda, L. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163859 · Cited by 22

Four genes relevant to pathological grade and prognosis in ovarian cancer

Pan, X., Chen, Y., & Gao, S. (2020) · Cancer Biomarkers · doi:10.3233/cbm-191162 · Cited by 22

Chemokines and Bone

Gilchrist, A. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_349 · Cited by 22

Recent advances in understanding osteosarcoma and emerging therapies

Gaspar, N., Costa, M. E. M. D., Fromigué, O., Droit, R., Berlanga, P., & Marchais, A. (2020) · Faculty Reviews · doi:10.12703/r/9-18 · Cited by 22

Interaction gene set between osteoclasts and regulatory CD4+ T cells can accurately predict the prognosis of patients with osteosarcoma

Li, F., Tang, H., Luo, X., Li, X., Luo, K., Liu, S., Liang, J., Liao, S., Zhong, C., Zhan, X., et al. (2023) · Cancer Science · doi:10.1111/cas.15821 · Cited by 22

Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma

Sun, W. Y., Ma, X., Shen, J., Yin, F., Wang, C., & Cai, Z. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2657 · Cited by 21

Cross-Species Gene Expression Analysis Reveals Gene Modules Implicated in Human Osteosarcoma

Jin, Z., Liu, S., Zhu, P., Tang, M., Wang, Y., Tian, Y., Li, D., Zhu, X., Yan, D., & Zhu, Z. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00697 · Cited by 21

Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes

Wei, Q., Yan, Q., Lv, M., Song, D., Wang, X., & Tian, K. (2021) · Pathology & Oncology Research · doi:10.3389/pore.2021.1609782 · Cited by 22

Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory

Martínez-Vélez, N., Laspidea, V., Zalacain, M., Labiano, S., García-Moure, M., Puigdelloses, M., Marrodan, L., Gonzalez-Huarriz, M., Herrador, G., de la Nava, D., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0565 · Cited by 21

Identification of osteosarcoma m6A-related prognostic biomarkers using artificial intelligence: RBM15

Jiang, J., Qu, H., Zhan, X., Liu, D., Liang, T., Chen, L., Huang, S., Sun, X., Chen, J., Chen, T., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-28739-1 · Cited by 21

A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy

He, Y., Ma, J., & Ye, X. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3126 · Cited by 21

Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma

Zhang, W., Lyu, P., Andreev, D., Jia, Y., Zhang, F., & Bözec, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.974851 · Cited by 20

Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma

Zhang, Z., Zhu, Z., Fu, J., Liu, X., Mi, Z., Tao, H., & Fan, H. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109684 · Cited by 20

MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment

Zhou, H., Jia, W., Lu, L., & Han, R. (2023) · Cancers · doi:10.3390/cancers15030824 · Cited by 21

Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesis

Hemmings, C. (2013) · Pathology · doi:10.1097/pat.0b013e328360b600 · Cited by 20

Tumor‐targeted and immune‐targeted monoclonal antibodies: Going from passive to active immunotherapy

Marabelle, A., & Gray, J. C. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25508 · Cited by 20

High Expression of PQBP1 and Low Expression of PCK2 are Associated with Metastasis and Recurrence of Osteosarcoma and Unfavorable Survival Outcomes of the Patients

Zhang, Y., Zhao, H., Wu, X., Jiang, D., Huang, L., & Li, L. (2019) · Journal of Cancer · doi:10.7150/jca.28480 · Cited by 21

Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients

Baron, M., Drohat, P., Crawford, B., Hornicek, F. J., Best, T. M., & Kouroupis, D. (2023) · Bioengineering · doi:10.3390/bioengineering10101187 · Cited by 19

A Dual Approach with Organoid and CRISPR Screening Reveals ERCC6 as a Determinant of Cisplatin Resistance in Osteosarcoma

Xu, R., Zhu, S., Zhang, W., Xu, H., Tu, C., Wang, H., Wang, L., He, N., Liu, T., Guo, X., et al. (2025) · Advanced Science · doi:10.1002/advs.202500632 · Cited by 19

Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma

Jiang, F., Wu, C., Wang, M., Wei, K., Zhou, G., & Wang, J. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.10.030 · Cited by 19

Comprehensive analysis of copper-metabolism-related genes about prognosis and immune microenvironment in osteosarcoma

Lin, Z., He, Y., Wu, Z., Yuan, Y., Li, X., & Luo, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-42053-w · Cited by 19

Targeted transcriptional profiling of the tumor microenvironment reveals lymphocyte exclusion and vascular dysfunction in metastatic osteosarcoma

Sorenson, L., Fu, Y., Hood, T., Warren, S. E., & McEachron, T. A. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1629779 · Cited by 20

Extracellular Vesicles in Osteosarcoma: Antagonists or Therapeutic Agents?

Martino, V. D., Rossi, M., Battafarano, G., Pepe, J., Minisola, S., & Fattore, A. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212586 · Cited by 19

Osteosarcoma exocytosis of soluble LGALS3BP mediates macrophages toward a tumoricidal phenotype

Li, J., Zhao, C., Li, Y., Wen, J., Wang, S., Wang, D., Dong, H., Wang, D., Zhao, Y., Wang, X., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.12.023 · Cited by 19

Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients

Buddingh, E. P., Ruslan, S. E. N., Berghuis, D., Gelderblom, H. A. J., Anninga, J., Hogendoorn, P. C. W., Egeler, R. M., Schilham, M. W., & Lankester, A. C. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1232-6 · Cited by 19

Microenvironment matters: insights from the FOSTER consortium on microenvironment-driven approaches to osteosarcoma therapy

Dutour, A., Pasello, M., Farrow, L., Amer, M. H., Entz‐Werlé, N., Nathrath, M., Scotlandi, K., Mittnacht, S., & Gomez‐Brouchet, A. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10257-3 · Cited by 21

CDKL3 promotes osteosarcoma progression by activating Akt/PKB

He, A., Ma, L., Huang, Y., Zhang, H., Duan, W., Li, Z., Teng, F., Yuan, J., Wu, H., Liu, L., et al. (2020) · Life Science Alliance · doi:10.26508/lsa.202000648 · Cited by 19

Ablative and Immunostimulatory Effects of Histotripsy Ablation in a Murine Osteosarcoma Model

Hay, A. N., Imran, K. M., Hendricks-Wenger, A., Gannon, J. M., Sereno, J., Simon, A., López, V. A. Q., Coutermarsh‐Ott, S. L., Vlaisavljevich, E., Allen, I. C., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102737 · Cited by 18

The tumor microenvironment of metastatic osteosarcoma in the human and canine lung

McGee, L. E., Pereira, J. D. S., McEachron, T. A., Mazcko, C. N., LeBlanc, A. K., & Beck, J. A. (2025) · Communications Biology · doi:10.1038/s42003-025-07992-2 · Cited by 18

Is Microscopic Vascular Invasion in Tumor Specimens Associated with Worse Prognosis in Patients with High-grade Localized Osteosarcoma?

Tsuda, Y., Tsoi, K. M., Stevenson, J. D., Parry, M., Fujiwara, T., Sumathi, V. P., & Jeys, L. M. (2020) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000001079 · Cited by 18

Effect of tumor-associated macrophages on lncRNA PURPL/miR-363/PDZD2 axis in osteosarcoma cells

He, F., Ding, G., Jiang, W., Fan, X.-L., & Zhu, L. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00700-z · Cited by 18

SKP2 Knockout in Rb1/p53–Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable Prognosis

Ferrena, A., Wang, J., Zhang, R., Karadal-Ferrena, B., Al-Hardan, W., Singh, S., Borjihan, H., Schwartz, E. L., Zhao, H., Oktay, M. H., et al. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0173 · Cited by 18

Early Lymphocyte Recovery and Outcome in Osteosarcoma

Lee, L. H., Lin, F., Pope, J., & Wagner, L. M. (2016) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000717 · Cited by 17

Multiomics integration analysis identifies tumor cell-derived MIF as a therapeutic target and potentiates anti-PD-1 therapy in osteosarcoma

Chen, W., Liao, Y., Yao, H., Zou, Y., Ji, F., Zhang, J., Guo, Z., Tu, J., Chen, J., Huo, Z., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-011091 · Cited by 17

A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target

Franceschini, N., Gaeta, R., Krimpenfort, P., Bruijn, I. H. B., Kruisselbrink, A. B., Szuhai, K., Palubeckaitė, I., Cleton-Jansen, A., & Bovée, J. V. M. G. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00709-z · Cited by 16

Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)

Barnes, D., Dutton, P., Bruland, Ø. S., Gelderblom, H. A. J., Faleti, A., Bühnemann, C., van Maldegem, A. M., Johnson, H., Poulton, L., Love, S., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09697-9 · Cited by 16

Biodegradable photothermal thermosensitive hydrogels treat osteosarcoma by reprogramming macrophages

Luo, G., Xu, Z., Zhong, H., Shao, H., Liao, H., Liu, N., Jiang, X., Zhang, Y., & Ji, X. (2023) · Biomaterials Science · doi:10.1039/d2bm01900k · Cited by 16

Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma

Zhang, Y., Gan, W., Ru, N., Xue, Z., Chen, W., Chen, Z., Wang, H., & Zheng, X. (2023) · Journal of bone oncology · doi:10.1016/j.jbo.2023.100481 · Cited by 16

Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice

Costa, M. E. M. D., Daudigeos‐Dubus, E., Gomez‐Brouchet, A., Bawa, O., Rouffiac, V., Serra, M., Scotlandi, K., Santos, C., Geoerger, B., & Gaspar, N. (2018) · Cancer Medicine · doi:10.1002/cam4.1346 · Cited by 16

Applying Osteosarcoma Immunology to Understand Disease Progression and Assess Immunotherapeutic Response

Pratt, H. G., Justin, E. M., & Lindsey, B. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_6 · Cited by 16

Hexokinase 2 is a transcriptional target and a positive modulator of AHR signalling

Watzky, M., Huard, S., Juricek, L., Dairou, J., Chauvet, C., Coumoul, X., Letessier, A., & Miotto, B. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac360 · Cited by 16

Putative Multifunctional Signature of Lung Metastases in Dedifferentiated Chondrosarcoma

Malchenko, S., Seftor, E. A., Nikolsky, Y., Hasegawa, S. L., Kuo, S.-M., Stevens, J. W., Poyarkov, S., Nikolskaya, T., Kucaba, T. A., Wang, M., et al. (2012) · Sarcoma · doi:10.1155/2012/820254 · Cited by 16

PD-L1 Expression in Carcinosarcomas of the Gynecologic Tract: A Potentially Actionable Biomarker

Pinto, A., Mackrides, N., & Nadji, M. (2016) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000457 · Cited by 16

Construction and Validation of a Macrophage-Associated Risk Model for Predicting the Prognosis of Osteosarcoma

Xiao, K.-W., Liu, Z., Zeng, Z., Yan, F., Xiao, L., Li, J.-L., & Cai, L. (2021) · Journal of Oncology · doi:10.1155/2021/9967954 · Cited by 15

The Heterogeneity of Infiltrating Macrophages in Metastatic Osteosarcoma and Its Correlation with Immunotherapy

Wang, Z., Wu, H., Chen, Y., Chen, H., Yuan, W., & Wang, X. (2021) · Journal of Oncology · doi:10.1155/2021/4836292 · Cited by 15

Identification of a Solute Carrier Family-Based Signature for Predicting Overall Survival in Osteosarcoma

Zheng, D., Wei, Z., & Guo, W. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.849789 · Cited by 15

Clinicopathological correlation of tumor-associated macrophages in Ewing sarcoma

Handl, M., Hermanová, M., Hotárková, S., Jarkovský, J., Múdrý, P., Shatokhina, T., Vesela, M., Štěrba, J., & Zambo, I. S. (2017) · Biomedical Papers · doi:10.5507/bp.2017.049 · Cited by 15

A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma

Wang, X., Xia, G., Xiao, S., Wu, S. J., Zhang, L., Huang, J., Zhang, W., & Cao, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1024915 · Cited by 14

Curculigoside exhibits multiple therapeutic efficacy to induce apoptosis and ferroptosis in osteosarcoma via modulation of ROS and tumor microenvironment

Ma, Z., Wang, Y., Zhang, X., Ding, S., Fan, J., Li, T. X., Xiao, X., & Li, J. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.102745 · Cited by 14

Integrins identified as potential prognostic markers in osteosarcoma through multi-omics and multi-dataset analysis

Cui, L., Zhao, S., Teng, H., Yang, B., Liu, Q., & Qin, A. (2025) · npj Precision Oncology · doi:10.1038/s41698-024-00794-5 · Cited by 14

Dual Regulation of Sprouty 4 Palmitoylation by ZDHHC7 and Palmitoyl-Protein Thioesterase 1: A Potential Therapeutic Strategy for Cisplatin-Resistant Osteosarcoma

Huang, T., Chen, Y., Zhao, Q., Wu, X., Li, H., Luo, X., Su, Y., Zhang, S., Liu, P., & Tang, N. (2025) · Research · doi:10.34133/research.0708 · Cited by 14

Advance of nano anticancer therapies targeted on tumor-associated macrophages

Wang, M., Zhao, J., Xiong, H., Lu, H., Jiang, H., & Wang, X. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214126 · Cited by 14

MCAM is associated with metastasis and poor prognosis in osteosarcoma by modulating tumor cell migration

Du, X., Zhang, Q., Wang, S., Chen, X., & Wang, Y. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24214 · Cited by 14

Identification of LTF as a Prognostic Biomarker for Osteosarcoma

Liu, X., Wang, Z., Liu, M., Zhi, F., Wang, P., Liu, X., Yu, S., Liu, B., & Jiang, Y. (2022) · Journal of Oncology · doi:10.1155/2022/4656661 · Cited by 14

The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma

Su, Z., Wang, C., Pan, R., Li, H., Chen, J., Tan, J., Tian, X., Lin, T., & Shen, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1028263 · Cited by 14

Identification of key genes in osteosarcoma by meta‑analysis of gene expression microarray

Sun, J., Xu, H., Qi, M., Zhang, C., & Shi, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10543 · Cited by 15

From biology to personalized medicine: Recent knowledge in osteosarcoma

Mohr, A., Costa, M. E. M. D., Fromigué, O., Audinot, B., Balde, T., Droit, R., Abbou, S. D., Khneisser, P., Berlanga, P., Pérez, E., et al. (2024) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2024.104941 · Cited by 13

Analysis of the effects of M 2 macrophage‐derived PDE 4 C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma

Pan, F., Pan, R., Hu, R., Zhang, H., Lei, S., Zhang, L., Zhou, C., Zeng, Z., Tian, X., & Xie, Q. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18395 · Cited by 14

Comprehensive analysis to identify PUS7 as a prognostic biomarker from pan-cancer analysis to osteosarcoma validation

Dong, B., Wang, B., Fan, M., Zhang, J., & Zhao, Z. (2024) · Aging · doi:10.18632/aging.205863 · Cited by 13

The Evolving Applications of Bispecific Antibodies: Reaping the Harvest of Early Sowing and Planting New Seeds

Ellerman, D. A. (2024) · BioDrugs · doi:10.1007/s40259-024-00691-0 · Cited by 13

STAT3 inhibition in combination with CD47 blockade inhibits osteosarcoma lung metastasis

Shrestha, P., Shrestha, R., Zhou, Y. L., Zielinski, R. J., Priebe, W., & Kleinerman, E. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1608375 · Cited by 13

SELPLG Expression Was Potentially Correlated With Metastasis and Prognosis of Osteosarcoma

Wang, B., & Sun, Y. (2022) · Pathology & Oncology Research · doi:10.3389/pore.2022.1610047 · Cited by 13

Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma

Hattinger, C. M., Salaroglio, I. C., Fantoni, L., Godel, M., Casotti, C., Kopecka, J., Scotlandi, K., Ibrahim, T., Riganti, C., & Serra, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010799 · Cited by 14

Establishment and validation of prognostic nomograms to predict overall survival and cancer-specific survival for patients with osteosarcoma

Yang, Q., Lai, Q., Wang, Y., Wang, Y., Yao, Z., & Zhang, X. (2020) · Neoplasma · doi:10.4149/neo_2020_200617n639 · Cited by 13

Extracellular Vesicles from Highly Metastatic Osteosarcoma Cells Induce Pro‐Tumorigenic Macrophage Phenotypes

Griffin, K. H., Mizenko, R. R., Arun, V., Carney, R. P., & Leach, J. K. (2024) · Advanced Biology · doi:10.1002/adbi.202300577 · Cited by 12

Machine learning survival prediction using tumor lipid metabolism genes for osteosarcoma

Li, S., Zheng, Z., & Wang, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-63736-y · Cited by 12

Immune Microenvironment in Childhood Cancers: Characteristics and Therapeutic Challenges

Pathania, A. S. (2024) · Cancers · doi:10.3390/cancers16122201 · Cited by 16

CD103+ cDC1 Dendritic Cell Vaccine Therapy for Osteosarcoma Lung Metastases

Yang, Y., Zhou, Y., Wang, J., Zhou, Y. L., Watowich, S. S., & Kleinerman, E. S. (2024) · Cancers · doi:10.3390/cancers16193251 · Cited by 12

PDK1-dependent metabolic reprogramming regulates stemness and tumorigenicity of osteosarcoma stem cells through ATF3

Tokumura, K., Fukasawa, K., Ichikawa, J., Sadamori, K., Hiraiwa, M., & Hinoi, E. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07903-7 · Cited by 12

Therapeutic radiation exposure of the abdomen during childhood induces chronic adipose tissue dysfunction

Huang, X., Maguire, O. A. B., Walker, J. M., Jiang, C. S., Carroll, T. S., Luo, J., Tonorezos, E. S., Friedman, D. N., & Cohen, P. (2021) · JCI Insight · doi:10.1172/jci.insight.153586 · Cited by 12

Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells

Тодосенко, Н. М., Yurova, K. A., Хазиахматова, О. Г., Malashchenko, V. V., Хлусов, И. А., & Litvinova, L. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102181 · Cited by 12

The analysis of the pyroptosis-related genes and hub gene TP63 ceRNA axis in osteosarcoma

Han, J., Hu, Y., Ding, S., Liu, S., & Wang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974916 · Cited by 12

Identification and Functional Analysis of EPOR + Tumor‐Associated Macrophages in Human Osteosarcoma Lung Metastasis

Li, Y., Li, M., Wei, R., & Wu, J. (2020) · Journal of Immunology Research · doi:10.1155/2020/9374240 · Cited by 12

Progress in immune microenvironment, immunotherapy and prognostic biomarkers in pediatric osteosarcoma

Zhang, L., Jiang, H., & Ma, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1548527 · Cited by 11

Immunotherapeutic Strategies in the Management of Osteosarcoma

Supra, R., & Agrawal, D. K. (2023) · Journal of Orthopaedics and Sports Medicine · doi:10.26502/josm.511500076 · Cited by 11

Surface Markers and Chemokines/Cytokines of Tumor-Associated Macrophages in Osteosarcoma and Other Carcinoma Microenviornments—Contradictions and Comparisons

Tatsuno, R., Komohara, Y., Pan, C., Kawasaki, T., Enomoto, A., Jubashi, T., Kono, H., Wako, M., Ashizawa, T., Haro, H., et al. (2024) · Cancers · doi:10.3390/cancers16162801 · Cited by 10

YKL ‐40 protein in osteosarcoma tumor tissue

Thorn, A., Daugaard, S., Christensen, L. H., Christensen, I. J., & Petersen, M. M. (2016) · Apmis · doi:10.1111/apm.12524 · Cited by 11

MicroRNA Expression Changes and Integrated Pathways Associated With Poor Outcome in Canine Osteosarcoma

Dailey, D. D., Hess, A. M., Bouma, G. J., & Duval, D. L. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.637622 · Cited by 11

NTRK fusions are extremely rare in bone tumours

Lam, S. W., Bruijn, I. H. B., van Wezel, T., Cleven, A. H. G., Hogendoorn, P. C. W., Cleton-Jansen, A., & Bovée, J. V. M. G. (2021) · Histopathology · doi:10.1111/his.14432 · Cited by 12

Evaluation of the Chemotherapy Drug Response Using Organotypic Cultures of Osteosarcoma Tumours from Mice Models and Canine Patients

Brulin, B., Nolan, J., Marangon, T., Kovacevic, M., Chatelais, M., Meheust, P., Abadie, J., Nail, L. L., Rosset, P., Brennan, M. Á., et al. (2021) · Cancers · doi:10.3390/cancers13194890 · Cited by 11

Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy

Cersosimo, F., Lonardi, S., Bernardini, G., Telfer, B., Mandelli, G. E., Santucci, A., Vermi, W., & Giurisato, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155207 · Cited by 280

Identification of Immune-Related Genes MSR1 and TLR7 in Relation to Macrophage and Type-2 T-Helper Cells in Osteosarcoma Tumor Micro-Environments as Anti-metastasis Signatures

Chen, Z., Huang, H., Wang, Y., Zhan, F., & Quan, Z. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.576298 · Cited by 18

Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma

Dumars, C., Ngyuen, J.-M., Gaultier, A., Lanel, R., Corradini, N., Gouin, F., Heymann, D., & Heymann, M. (2016) · Oncotarget · doi:10.18632/oncotarget.13055 · Cited by 183

Tumor-associated macrophages in osteosarcoma

Zhao, Y., Zhang, B., Zhang, Q., Ma, X., & Feng, H. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100029 · Cited by 37

Macrophage-centered immunotherapy for osteosarcoma: mechanisms, repolarization, and translational strategies

Li, Z., Lin, D., Wu, L., Xu, W., Zhang, H., Zhuang, Z., Zhang, L., Chen, J., & Su, Z. (2026) · World Journal of Surgical Oncology · doi:10.1186/s12957-026-04288-5 · Cited by 3